?
Læs mere om arbejdspladslogin her.

Content area

Videnskab / 6. feb 2017

Mohs’ kirurgi til behandling af basalcellekarcinom

Statusartikel
Dato
6. feb 2017
Forfattere
Martin Glud1, Silje Haukali Omland1, John Paoli2 & Robert Gniadecki1, 3 1) Dermato-venerologisk Afdeling, Bispebjerg Hospital 2) Hudmottagning, Sahlgrenska Universitetssjukhuset, Göteborg 3) Det Sundhedsvidenskabelige Fakultet, Københavns Universitet Ugeskr Læger 2017;179:V07160501
💬 0
Reference: 
Ugeskr Læger 2017;179:V07160501
Blad nummer: 
Sidetal: 
2-5
Mohs surgery for basal cell carcinoma
Micrographic surgery is currently the only technique which ensures complete removal of basal cell carcinomas. The major limitation is the high set-up cost, which is particularly connected with specialized training of surgeons, techni­cians and the set-up of a histology facility for frozen tissue sectioning and staining. In the long run, however, the cost of Mohs surgery per patient does not exceed that of conven­tional surgery. The technique is very safe and has multiple advantages over any other treatment modality. It achieves the highest cure rates, it is minimally invasive, it is tissue-sparing and it enables the optimal closure of the surgical defect. Mohs surgery is cost-effective, especially when dealing with poorly demarcated, high-risk, facial tumours, where it should be considered as the first choice of treatment.

💬 0 Kommentarer

Du skal være logget ind for at læse denne artikel
Log ind

Du kan også købe adgang

Køb abonnement til Ugeskriftet.dk (der er forskellige abonnementstyper )

Right side

Nr. 16/2017

EmediateAd

EmediateAd

Senest kommenteret

Afgørende møde for almen praksis’ fremtid i dag
💬
2
Jens Søndergaard Jensen 18. aug 2017 20:23
Kunstig intelligens: krystalkugle eller sæbeboble?
💬
1
Andreas Hover Lundh 15. aug 2017 09:56
Praktiserende læger vil ikke udskrive cannabis
💬
6
Asger Lau Dalmose 14. aug 2017 21:03
For og imod medicinsk cannabis
💬
4
Hanne Hulgaard 14. aug 2017 18:53
Sequelae til et fejlplaceret centralt venekateter
💬
6
Mats Lindberg 10. aug 2017 08:43

EmediateAd

EmediateAd

EmediateAd

EmediateAd